| T1015 | Clinic visit/encounter, all-inclusive | 102 | 180 | 8,540 | $180 | $3M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 135 | 460 | 1,240 | $30 | $190K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 193 | 480 | 1,030 | $20 | $128.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 142 | 170 | 380 | $50 | $63.7K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 68 | 70 | 220 | $70 | $54K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 102 | 190 | 390 | $20 | $42.6K |
| G0008 | Administration of influenza virus vaccine | 156 | 260 | 110 | $20 | $17.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 102 | 160 | 770 | $1 | $7.8K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 31 | 40 | 60 | $30 | $5.7K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 110 | 190 | 110 | $1 | $5.7K |